ICON Public Limited Company
NASDAQ:ICLRMedical - Diagnostics & Research
-$0.27 today
- Market cap
- $14.62B
- Beta
- 1.27
- P/E (TTM)
- 23.0
- EPS (TTM)
- $6.23
Volume 0.55M
Average 1.15M
ICLR Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
ICON Public Limited CompanyNASDAQ: ICLR
Cash & Equivalents · Q2 FY2026 · quarter ended Jun 2026
Cash & equivalents rises 137.8% from a year ago
Cash & equivalents stood at $928.38M at the end of Q2 FY2026, up 137.8% from a year earlier and up 21.3% from the prior quarter. Over 3 fiscal years it compounded at +30.9% a year.
Context
- Cash & equivalents amounted to 5.7% of total assets at the end of Q2 FY2026, up 3.3 pp from a year earlier.
- Cash & equivalents increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +137.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 647.3M USD
- Year-over-year change
- +20.1%
- 4-year CAGR
- -3.7%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 647.3M | +20.1% |
| FY2024 | 2024-12-31 | 538.79M | +42.5% |
| FY2023 | 2023-12-31 | 378.1M | +30.9% |
| FY2022 | 2022-12-31 | 288.77M | -61.6% |
| FY2021 | 2021-12-31 | 752.21M | — |
Cash & Equivalents vs competitors
How ICLR compares with its peers on the latest reported figures
- ICLR's Jun 2026 cash & equivalents of $928.38M is the 2nd highest of the 6 companies compared; the peer median is $192.03M.
- Its year-over-year change of +137.8% is the 2nd highest of 6, against a peer median of +5.0%.
- Cash & equivalents amounts to 5.7% of total assets for ICLR, versus a peer median of 6.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $1.91B | -6.4% | +17.6% | 6.4% | |
| Jun 2026 | $928.38M | +137.8% | +30.9% | 5.7% | |
| Sep 2026 | $705.32M | +147.2% | +160.0% | 30.6% | |
| Jun 2026 | $192.03M | +5.0% | -3.0% | 2.5% | |
FTREFortrea Holdings Inc. | Jun 2026 | $168.6M | +107.6% | +16.0% | 6.2% |
| Jun 2026 | $141.8M | -78.1% | +18.4% | 0.8% | |
| Peer median (excluding ICLR) | $192.03M | +5.0% | +17.6% | 6.2% | |
Competitors are the stored peer set for ICLR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 752.21M | 288.77M | 378.1M | 538.79M | 647.3M |
| Short-term Investments | 1.71M | 1.71M | 1.95M | 0 | 0 |
| Net Receivables | 2.07B | 2.8B | 2.9B | 2.85B | 2.75B |
| Inventory | 0 | 7.06M | 0 | 0 | 0 |
| Other Current Assets | 0 | 130.03M | 132.11M | 140.44M | 105.32M |
| Total Current Assets | 2.94B | 3.23B | 3.41B | 3.53B | 3.5B |
| Property, Plant & Equipment (Net) | 534.57M | 504.15M | 501.52M | 530.48M | 524.67M |
| Goodwill | 9.04B | 8.97B | 9.02B | 9.05B | 8.73B |
| Intangible Assets | 4.71B | 4.28B | 3.86B | 3.56B | 3.25B |
| Long-term Investments | 24.97M | 32.63M | 46.8M | 57.95M | 82.05M |
| Tax Assets | 48.39M | 76.93M | 73.66M | 74.76M | 106.87M |
| Other Non-current Assets | 89.19M | 92.17M | 78.47M | 72.8M | 75.71M |
| Total Non-current Assets | 14.45B | 13.96B | 13.58B | 13.35B | 12.77B |
| Total Assets | 17.39B | 17.19B | 16.99B | 16.88B | 16.27B |
| Account Payables | 226.98M | 611.4M | 595.47M | 704.59M | 780.85M |
| Short-term Debt | 55.15M | 55.15M | 110.15M | 29.76M | 529.76M |
| Tax Payables | 59.43M | 41.78M | 13.97M | 55.26M | 19M |
| Deferred Revenue | 1.32B | 1.51B | 1.65B | 1.61B | 1.55B |
| Other Current Liabilities | 439.82M | 24.82M | 415.06M | 355.22M | 279.74M |
| Total Current Liabilities | 2.48B | 2.69B | 2.83B | 2.8B | 3.2B |
| Long-term Debt | 5.38B | 4.6B | 3.67B | 3.4B | 2.87B |
| Deferred Tax Liabilities | 1.09B | 988.59M | 899.1M | 812.49M | 714.43M |
| Deferred Revenue (Non-current) | 735K | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 213.97M | 277.45M | 232.65M | 209.3M | 176.06M |
| Total Non-current Liabilities | 6.84B | 6B | 4.92B | 4.56B | 3.88B |
| Total Liabilities | 9.32B | 8.69B | 7.75B | 7.35B | 7.08B |
| Common Stock | 6.64M | 6.65M | 6.7M | 6.59M | 6.31M |
| Retained Earnings | 1.42B | 1.82B | 2.43B | 2.72B | 2.12B |
| Accumulated OCI | (90.94M) | (171.54M) | (142.34M) | (228.63M) | (68.53M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 1.61M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 8.07B | 8.5B | 9.24B | 9.52B | 9.19B |
| Total Debt | 5.65B | 4.83B | 3.94B | 3.6B | 3.56B |
| Net Debt | 4.89B | 4.54B | 3.56B | 3.06B | 2.91B |
ICON Public Limited Company
NASDAQ:ICLR
Intrinsic Alpha fair value
Locked
Current Price
$195.16
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.